Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
31.20%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth31.20%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
4.4
41.93%
60%
—
-100.00%
20%
—
5 Years
Score4.4
Net Growth41.93%
Net Trend60%
Net Income Consistency—
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency—
Anixa Biosciences Inc fundamental performance
Between 2020 and 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 10M to -$ 10M. Revenue increased in 1 of those 5 years; net income in 3.
Between 2015 and 2025, revenue declined from $ 9M to $ 0.00 and net income went from -$ 1M to -$ 10M. Revenue increased in 4 of those 10 years; net income in 6.
Anixa Biosciences Inc currently holds a 20-year HDB Score of 2.6 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.23 | — |
1 Year2025-08-12 | $ 3.04 | 6.25% |
5 Years2021-08-12 | $ 4.19 | -22.91% |
10 Years2016-08-12 | $ 3.23 | 0.00% |
20 Years2006-08-11 | $ 15.50 | -79.16% |
30 Years1996-08-12 | $ 153.13 | -97.89% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 |
|---|---|---|---|---|---|---|
| Price | $ 3.23 | $ 3.04 | $ 4.19 | $ 3.23 | $ 15.50 | $ 153.13 |
| Return | — | 6.25% | -22.91% | 0.00% | -79.16% | -97.89% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 7M | $ 13M |
| 2025 | $ 0.00 | -$ 10M | $ 15M |
| 2024 | $ 0.00 | -$ 12M | $ 19M |
| 2023 | $ 210K | -$ 9M | $ 23M |
| 2022 | $ 2.46B | -$ 13M | $ 29M |
| 2021 | $ 512K | -$ 12M | $ 35M |
| 2020 | $ 0.00 | -$ 10M | $ 9M |
| 2019 | $ 250K | -$ 11M | $ 5M |
| 2018 | $ 1M | -$ 13M | $ 5M |
| 2017 | $ 362.5K | -$ 5M | $ 6M |
| 2016 | $ 300K | -$ 5M | $ 3M |
| 2015 | $ 9M | -$ 1M | $ 6M |
| 2014 | $ 3M | -$ 9M | $ 5M |
| 2013 | $ 388.85K | -$ 10M | $ 898.17K |
| 2012 | $ 940.01K | -$ 4M | $ 839.69K |
| 2011 | $ 1M | -$ 7M | $ 3M |
| 2010 | $ 730.67K | -$ 5M | $ 1M |
| 2009 | $ 1M | -$ 16M | $ 2M |
| 2008 | $ 2M | -$ 5M | $ 1M |
| 2007 | $ 486.85K | -$ 5M | $ 1M |
| 2006 | $ 508.65K | -$ 7M | $ 1M |
| 2005 | $ 439.79K | -$ 4M | $ 506.52K |
| 2004 | $ 494.46K | -$ 3M | $ 1M |
| 2003 | $ 244.22K | -$ 3M | $ 1M |
| 2002 | $ 5M | -$ 3M | $ 854.82K |
| 2001 | $ 1M | -$ 3M | $ 1M |
| 2000 | $ 1M | -$ 4M | $ 1M |
| 1999 | $ 100K | -$ 8M | $ 2M |
| 1998 | $ 100K | -$ 7M | $ 5M |
| 1997 | $ 100K | -$ 5M | $ 12M |
| 1996 | $ 100K | -$ 5M | $ 22M |
| 1995 | $ 100K | -$ 3M | $ 8M |
| 1994 | $ 100K | -$ 3M | $ 6M |
| 1993 | $ 100K | -$ 2M | $ 8M |
| 1992 | $ 100K | -$ 1M | $ 4M |
| 1991 | $ 100K | -$ 1M | $ 4M |
| 1990 | $ 100K | -$ 1M | $ 2M |
| 1989 | $ 100K | -$ 1M | $ 2M |
| 1988 | $ 100K | -$ 1M | $ 1M |
| IPO1987 | $ 100K | -$ 1M | $ 700K |
Explore beyond ANIX
You're looking at Anixa Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
